Certainly.
Thank you again for the important question.
The Patented Medicine Prices Review Board works to try to establish a pricing regime and a regulatory overview for Canada. They do have a series of countries that they look at as comparators for determining whether the prices for patented medicines are fair in the Canadian context. There is a group of countries, as the member noted, and they currently are used from time to time.
There are proposals put forward about possible changes to that group, and those proposals do come forward from time to time, but it's not something that is currently being implemented. Currently, the PMPRB is working very hard and diligently with the regulatory framework and with the group of comparator countries that is currently in force.